Sanofi Q3 2012 - Interview with CFO Jérôme Contamine
Sanofi Q3 2012 - Interview with CFO Jérôme Contamine
PARIS--(BUSINESS WIRE)-- Sanofi, a global and diversified healthcare leader, reports results for the third-quarter of 2012. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on results and outlook.
Click to watch the video:http://bit.ly/T8WMTB
Topics covered in the interview include:
- Q3 2012 Results
- Diabetes
- Multiple Sclerosis
- Rare Diseases
- Vaccines
- Austerity in Europe
- Emerging Markets
- R&D pipeline
About Sanofi
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYS: SNY) .
Company website: www.sanofi.com
Sanofi
Investor Relations:
Sébastien Martel, +33 1 53 77 45 45
IR@sanofi.com
or
Media Relations:
+33 1 53 77 45 02
MR@sanofi.com
KEYWORDS: Europe France
INDUSTRY KEYWORDS:
The article Sanofi Q3 2012 - Interview with CFO Jérôme Contamine originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
